Viewing StudyNCT00119171



Ignite Creation Date: 2024-05-05 @ 11:44 AM
Last Modification Date: 2024-10-26 @ 9:12 AM
Study NCT ID: NCT00119171
Status: COMPLETED
Last Update Posted: 2008-10-16
First Post: 2005-07-05

Brief Title: Ispinesib In Combination With Capecitabine In Patients With Solid Tumors
Sponsor: GlaxoSmithKline
Organization: GlaxoSmithKline

Conditions & Keywords Data

Conditions:
Name
Solid Tumor Cancer
Keywords:
Name View
capecitabine View
Safety View
tolerability View
dose limiting toxicity View
solid tumors View